The company has not filed an annual or quarterly report since its Q3 FY2019 10-Q, filed Nov 6, 2019. Its latest SEC filing is a CT ORDER from Aug 20, 2021.
10-Q for Q3 FY2019, filed Nov 6, 2019
The sections below describe the company as of the FY2018 annual report.
Sells specialty phosphate and nutritional ingredients to food, beverage, health-product and industrial manufacturers.
10-K for FY2018, filed Feb 27, 2019Innophos is a leading international producer of specialty ingredient solutions that deliver versatile benefits for the food, health…View ↗
Many of Innophos’ products are application-specific compounds engineered to meet customer performance requirements and are often critical…View ↗
Innophos’ product offering includes a wide array of botanical, enzyme and mineral based nutritional ingredients. These products have…View ↗
Customers pay for products shipped or delivered under agreed sales terms; invoices are issued at shipment, and payment is due soon after.
10-K for FY2018, filed Feb 27, 2019
$801.8M
10-K for FY2018, filed Feb 27, 2019
$801.8M ↗
Consumer goods and specialty chemical manufacturers, as well as distributors, are customers; Innophos often works directly with customers to tailor ingredients for finished-product needs.
10-K for FY2018, filed Feb 27, 2019
Yes. It kept 4 cents of every revenue dollar as net income in .
10-K for FY2018, filed Feb 27, 2019
8-K, filed Feb 7, 2020
CRANBURY, NJ and NEW YORK, NY, February 7, 2020 – Innophos Holdings, Inc. (“Innophos” or the “Company”), a leading international producer…View ↗
8-K, filed Jan 22, 2020
In connection with proposed financing activities of Iris Merger Sub 2019, Inc. (“Merger Sub”), an affiliate of One Rock Capital Partners…View ↗
8-K, filed Oct 21, 2019
(i) each share of Company common stock, par value $0.001 per share (the “Company Common Stock”) issued and outstanding (other than shares…View ↗
8-K, filed Mar 15, 2019
On March 15, 2019, Innophos Holdings, Inc. (the “Company”) terminated the employment of Han Kieftenbeld, the Company’s Senior Vice…View ↗
Held flat. Revenue was $801.8M in , about the same as the $839.2M of .
Competes with Israel Chemicals, Nutrien, Mexichem, Balchem, Jost Chemical, Naturex, and BI Nutraceuticals
10-K for FY2018, filed Feb 27, 2019In connection with our Specialty Ingredients products, we face competition with respect to our phosphate products, as well as our…View ↗
Loading...
